Zhuo M, Guan Y, Yang X, Hong L, Wang Y, Li Z, Chen R, Abbas HA, Chang L, Gong Y, Wu N, Zhong J, Chen W, Chen H, Dong Z, Zhu X, Li J, Wang Y, An T, Wu M, Wang Z, Wang J, Roarty EB, Rinsurongkawong W, Lewis J, Roth JA, Swisher SG , Lee JJ, Heymach JV, Wistuba II, Kalhor N, Yang L, Yi X, Futreal PA, Glisson BS, Xia X, Zhang J, Zhao J
10.1124/mol.112.080697 Mol
found that inhibiting lactate export could also ameliorate hypertrophic phenotype transformation mediated by the pyruvate-lactate metabolic shuttle axis
For a comprehensive assessment of cardiometabolic risk alongside these performance markers, the Heart Vitality Panel adds important context, particularly in older patients for whom metabolic and cardiovascular risk tracking should proceed in parallel